Feb 6, 2026
reform still needed for insulin
Standards of Care accelerate access to diabetes technologies—removing C‑peptide and autoantibody prerequisites and recommending earlier use of CGM and automated insulin delivery (AID) systems—which pr...
House bill
A House bill aims to require private group plans to cover selected insulin products with constrained cost-sharing for enrollees 26 and younger starting in 2026.